Aims and Scope of Expert Opinion on Drug Delivery
Expert Opinion on Drug Delivery is a monthly peer-reviewed medical journal publishing review articles covering all aspects of research on drug delivery, from initial concept to potential therapeutic application and final relevance in clinical use. It was established in 2004 and is published by Taylor and Francis Group. The editor-in-chief is Uday Kompella (University of Colorado). Less
Key Metrics
CiteScore 

10.4
Eigenfactor 

0.005 - 0.01
Impact Factor 

5 - 10
SJR 

Q1Pharmaceutical Science

SNIP 

1.34
Recommended pre-submission checks
Powered by 

Topics Covered on Expert Opinion on Drug Delivery
Expert Opinion on Drug Delivery Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2004 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Opinion on Drug Delivery ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Expert Opinion on Drug Delivery
An overview of targeted drug delivery systems specific for fibroblast growth factor receptors and their co-receptors
- 3 Aug 2026
- Expert Opinion on Drug Delivery
Quality by design in advanced anticancer therapeutics: bridging design space, manufacturing, and clinical performance.
- 19 May 2026
- Expert opinion on drug delivery
Targeting the brain: alternative administration routes and drug delivery systems for antidepressant therapy
- 14 May 2026
- Expert Opinion on Drug Delivery
Immunomodulatory strategies and targeted delivery systems in atherosclerosis therapy
- 8 May 2026
- Expert Opinion on Drug Delivery
Advancing transdermal drug delivery: integration of microneedle technology and iontophoresis for enhanced therapeutic outcomes
- 8 May 2026
- Expert Opinion on Drug Delivery
Mechanistic and translational frontiers on “VEGF and TKI inhibitor axitinib”: unfolding drug delivery approaches and opportunities in cancer therapy
- 4 May 2026
- Expert Opinion on Drug Delivery
An overview of targeted drug delivery systems specific for fibroblast growth factor receptors and their co-receptors
- 3 Aug 2026
- Expert Opinion on Drug Delivery
Quality by design in advanced anticancer therapeutics: bridging design space, manufacturing, and clinical performance.
- 19 May 2026
- Expert opinion on drug delivery
Targeting the brain: alternative administration routes and drug delivery systems for antidepressant therapy
- 14 May 2026
- Expert Opinion on Drug Delivery
Immunomodulatory strategies and targeted delivery systems in atherosclerosis therapy
- 8 May 2026
- Expert Opinion on Drug Delivery
Advancing transdermal drug delivery: integration of microneedle technology and iontophoresis for enhanced therapeutic outcomes
- 8 May 2026
- Expert Opinion on Drug Delivery
Mechanistic and translational frontiers on “VEGF and TKI inhibitor axitinib”: unfolding drug delivery approaches and opportunities in cancer therapy
- 4 May 2026
- Expert Opinion on Drug Delivery